At this time, posts about Helixmith are surging on portals and stock communities, while foreign investors are tentatively estimated to have net sold 29,000 shares today. Helixmith is known as a company specializing in the development of new drugs centered on gene therapy.
As of 11:30 AM on the 21st, Helixmith's stock price is 20,550 KRW, up 4.85% from the previous day, with a trading volume of 2,694,175 shares, which is about 100.53% of the 5-day average trading volume. On October 20th, Helixmith became an issue in the market with the headline "Continuous sharp decline due to private equity fund losses."
In addition to Helixmith, posts from investors are also surging regarding Ssangyong Cement Preferred (003415), Iljeong Industrial (008500), and ABProBio (195990).

※Source: AI Investment Assistant AI Rassi
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

